TWO · 6574.TWO
Mikobeaute International Co., Ltd.
NT$113.50-NT$2.00 (-1.73%)
Mikobeaute International Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 26.3% below the high.
Loading market information…
TWO · 6242.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 02:53 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Li Kang Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Li Kang Biomedical Co., Ltd.’s forward annual dividend is NT$2.00 per share, paid annual. The forward yield is 6.06% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Li Kang Biomedical Co., Ltd. specializes in the development and distribution of nutritional supplements, cosmeceuticals, and health-focused beverages. Beyond its product lines, the company also provides consulting and operational support for tourism factories, and offers telemarketing solutions. Established in 1982, the firm initially operated under the name BAFO Technologies Corporation, before adopting its current moniker, Li Kang Biomedical Co., Ltd., in September 2014. The company maintains its headquarters in Tainan City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$113.50-NT$2.00 (-1.73%)
Mikobeaute International Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 26.3% below the high.
NT$43.50+NT$0.70 (+1.64%)
Grand Hall Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 7.45% below the high.
NT$15.10NT$0.00 (0.0%)
Kuangli Bio-Tech Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 52.81% below the high.
NT$41.10NT$0.00 (0.0%)
Far East Bio-Tec Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 12.55% below the high.
NT$20.75NT$0.00 (0.0%)
Sino Tactful Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.48% below the high.
NT$26.00-NT$0.10 (-0.38%)
Mao Bao Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.16% below the high.
NT$29.25NT$0.00 (0.0%)
Ace Edulink Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 4.1% below the high.
NT$24.00-NT$0.05 (-0.21%)
Tittot Company Limited’s quoted price sits in the lower half of its reported 52-week range, 36.0% below the high.
